Is There Still a Value in Testing for PD-L1 Expression in Advanced NSCLC Today? (BMIC-005)
Sep 05, 2017•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Jack West explains the potential value PD-L1 expression during the initial workup of patients with advanced NSCLC, in the face of a broad FDA approval for chemo/immunotherapy regardless of PD-L1 status in patients with advanced non-squamous NSCLC.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast